bioMérieux S.A.
General ticker "BMXMF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $15.2B (TTM average)
bioMérieux S.A. does not follow the US Stock Market performance with the rate: -9.0%.
Estimated limits based on current volatility of 0.2%: low 119.91$, high 120.34$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-10, amount 1.03$ (Y0.86%)
Short-term BMXMF quotes
Long-term BMXMF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €3,674.70MM | €3,979.90MM | €4,068.28MM |
| Operating Expenses | €3,235.70MM | €3,391.10MM | €3,507.29MM |
| Operating Income | €439.00MM | €588.80MM | €560.99MM |
| Non-Operating Income | €-1.60MM | €-9.50MM | €-35.69MM |
| Interest Expense | €1.60MM | €16.56MM | €0.00MM |
| R&D Expense | €540.30MM | €491.50MM | €507.21MM |
| Income(Loss) | €437.40MM | €579.30MM | €525.30MM |
| Taxes | €114.50MM | €154.30MM | €128.75MM |
| Profit(Loss)* | €357.60MM | €432.20MM | €397.35MM |
| Stockholders Equity | €3,752.20MM | €4,204.90MM | €4,100.56MM |
| Inventory | €908.50MM | €1,037.30MM | €959.34MM |
| Assets | €5,259.20MM | €5,770.00MM | €5,572.61MM |
| Operating Cash Flow | €445.40MM | €667.30MM | €788.00MM |
| Capital expenditure | €338.30MM | €345.80MM | €335.17MM |
| Investing Cash Flow | €-488.80MM | €-359.80MM | €-461.53MM |
| Financing Cash Flow | €-122.30MM | €-212.60MM | €-155.34MM |
| Earnings Per Share** | €3.01 | €3.67 | €3.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.